All the news Showing 10 of 938 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources HBV vaccination Studies from US and Spain show that hepatitis vaccination programmes not reaching target populations Michael Carter / 23 January 2012 The majority of US adults at risk of hepatitis B remain unvaccinated against the potentially life-threatening infection of hepatitis, according to research published in advance of print in the online edition of ... Side effects Common side-effects of hepatitis C protease inhibitors: clinical management advice published Michael Carter / 20 January 2012 The addition of the protease inhibitors telaprevir or boceprevir to hepatitis C treatment regimens increases the risk of anaemia, according to a review article published in Liver International. The author also found that ... Treatment guidelines Early guidance on use of hepatitis C protease inhibitors in HIV-co-infected patients Michael Carter / 29 December 2011 Doctors in the US state of Maryland have issued preliminary guidance for the use of hepatitis C protease inhibitors by patients co-infected with HIV. Published in the online edition of Clinical Infectious ... Hepatitis B Co-infection with hepatitis B worsens HIV-related outcomes Michael Carter / 13 December 2011 Co-infection with hepatitis B virus increases the risk of AIDS or death for patients newly diagnosed with HIV, investigators from the US military report in the online edition of the Journal of Infectious Diseases. ... Hepatitis B Hepatitis B genotype B associated with poorer liver-related outcomes in Taiwanese patients co-infected with HIV and hepatitis B Michael Carter / 13 December 2011 Liver-related outcomes are poorer in HIV-positive patients who are co-infected with hepatitis B virus genotype B compared to co-infected patients with hepatitis B genotype C, Taiwanese investigators report in the online edition of ... Disease course and symptoms Hepatitis C doesn't affect cognitive function of women, but some evidence HIV does Michael Carter / 08 December 2011 Infection with hepatitis C does not affect the cognitive performance of women with or at risk of HIV, according to data from the Women’s Interagency HIV Study (WIHS) published in the online ... Transmission and prevention Hepatitis C transmission via injecting drug use: look beyond needles and syringes Michael Carter / 04 November 2011 Important insights into the continued spread of hepatitis C among injecting drug users are provided by two studies published in the online edition of the Journal of Infectious Diseases. An international team of ... Treatment issues Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy Michael Carter / 04 November 2011 The persistence of a low viral load during the first twelve weeks of hepatitis C therapy is associated with an increased risk of relapse after the completion of treatment, investigators report in ... Treatment issues Hepatitis C drug boceprevir achieves 70% viral suppression rate in HIV co-infected people within 24 weeks Gus Cairns / 22 October 2011 Interim results presented at the Infectious Diseases Society of America (IDSA) conference yesterday show that 70.5% of 98 patients with HIV and hepatitis C who took the hepatitis C protease inhibitor (PI) drug ... Treatment for people living with HIV and HCV New European HIV treatment guidelines expand treatment recommendations but anticipate possible drug shortages Gus Cairns / 18 October 2011 The new edition of the European AIDS Clinical Society (EACS) treatment guidelines for people with HIV was published last week at the 13th European AIDS Conference in Belgrade, Serbia. ... ← Prev1...8990919293...94Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive